Skip to content

Author

Ahmet Akif Kızılkurtlu

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Jul 2026

Development of Eudragit L100/sodium alginate-carrageenan core/shell nanofiber patches for dermal delivery of omega-3 acid ethyl ester.

Oxidation-prone omega-3 acid ethyl esters offer biologically attractive lipid cues for skin repair and dermocosmetic applications; however, their topical translation is constrained by poor aqueous compatibility, chemical lability, and limited residence at the skin interface. Herein, a coaxially electrospun core-shell nanofiber patch was developed to compartmentalize docosahexaenoic/eicosapentaenoic acid (DHA/EPA)-containing omega-3 ethyl esters within an Eudragit L100 (EL100) core while presenting a sodium alginate-κ-carrageenan (SA-CRG) polysaccharide shell. Electrospinning parameters were systematically optimized by tuning the EL100 concentration, the ethanol/N,N-dimethylformamide ratio, and the core/shell flow rates, yielding smooth, bead-free fibers with a continuous core-shell architecture, as verified by SEM and TEM. Although Ca2⁺-mediated ionic crosslinking enhanced shell compactness and tensile integrity, FTIR/DSC and surface-wettability changes indicated DHA/EPA oxidation and lipid redistribution during aqueous post-treatment; therefore, the non-crosslinked 25EL100(5:5)-DHA + EPA/SA-CRG mats were selected for delivery and biological evaluation. The optimized fibers combined a hydrophilic skin-contacting surface with controlled swelling at pH 4.0 and sustained omega-3 release over 120 h, reaching cumulative DHA and EPA release of 88.5% and 72.9%, respectively. Release kinetics were best described by the Korsmeyer-Peppas model (R2 = 0.9912 for DHA; R2 = 0.9884 for EPA), with n values below 0.45, indicating predominantly diffusion-governed transport. The nanofibers were cytocompatible with human dermal fibroblasts, maintaining 91.81% viability for the DHA/EPA-loaded formulation versus 97.65% for the placebo, and promoted fibroblast wound-closure behavior in scratch assays. Complementary microplate-based turbidimetric assays further indicated that the antibacterial performance of the DHA/EPA-loaded mats was influenced by lipid oxidative status. Oxidized DHA/EPA-loaded mats exhibited concentration-dependent suppression of bacterial growth, with a stronger effect against the Gram-positive Staphylococcus aureus than against the Gram-negative Escherichia coli, whereas non-oxidized mats showed weaker activity. Overall, EL100/SA-CRG core-shell nanofibers provide a dry, handleable, and biologically tolerated platform for sustained topical delivery of labile omega-3 ethyl esters, thereby supporting their further development as advanced dermal patches for skin repair and dermocosmetic applications.

Merve Karataş, Kubra Aranci, Ahmet Akif Kızılkurtlu et al. · 0 citations
Review Open access Aug 2026

AI-Ready Multimodal Wearable Biosensors Beyond Glucose: Biofluid Sampling, Sensor Fusion, and Clinical Translation

Continuous glucose monitoring has established that a molecular signal can be repeatedly measured in daily life and translated into clinically meaningful action. The next frontier is broader: wearable biosensors that monitor metabolites, electrolytes, hormones, drugs, nutrients, inflammatory markers, and tissue-state indicators beyond glucose. This review proposes an artificial intelligence (AI)-ready framework for multimodal wearable biochemical monitoring. We organize the field as a complete measurement chain that links biofluid access, sampling chronology, flexible biointerfaces, molecular recognition, signal conditioning, metadata capture, sensor fusion, clinical validation, and lifecycle governance. The central argument is that the clinically useful variable is rarely a raw current, potential, optical intensity, or spectrum; it is a quality-controlled, context-aware, and uncertainty-aware digital biomarker. We compare sweat, interstitial fluid, saliva, tears, wound exudate, and breath condensate; evaluate enzymatic, ion-selective, affinity, transistor, optical, and spectroscopic sensing strategies; synthesize representative high-impact studies; and define minimum metadata, validation metrics, and translation gates. The review highlights recurring gaps in biofluid validity, real-world robustness, reference-comparator alignment, subgroup evidence, and algorithmic governance. We conclude with practical design rules for converting flexible biochemical wearables from attractive prototypes into clinically credible intelligent biosensing systems.

Ahmet Akif Kızılkurtlu, Ali Akpek · 0 citations